Rationale and Design of CHD PULSE: Congenital Heart Disease Project to Understand Lifelong Survivor Experience.

Adult congenital heart disease Long-term outcomes Outcomes Quality of life Survivors

Journal

American heart journal
ISSN: 1097-6744
Titre abrégé: Am Heart J
Pays: United States
ID NLM: 0370465

Informations de publication

Date de publication:
17 Sep 2024
Historique:
received: 18 07 2024
revised: 09 09 2024
accepted: 12 09 2024
medline: 20 9 2024
pubmed: 20 9 2024
entrez: 19 9 2024
Statut: aheadofprint

Résumé

With improved survival of adults with congenital heart disease (CHD) comes a need to understand the lifelong outcomes of this population. The aim of this paper is to describe the rationale and design of Congenital Heart Disease Project to Understand Lifelong Survivor Experience (CHD PULSE), a study to determine long-term medical, neurocognitive, and psychosocial outcomes among adults with a history of intervention for CHD and to identify factors associated with those outcomes. CHD PULSE is a cross-sectional survey conducted from September 2021 to April 2023 among adults aged 18 and older with a history of at least one intervention for CHD at one of 11 participating U.S. centers in the Pediatric Cardiac Care Consortium. Participants with CHD were asked to complete a 99-question survey on a variety of topics including: demographics, surgeries, health insurance, health care, heart doctors, general health, height and weight, education and work history, reproductive health (for women only), and COVID-19. To construct a control group for the study, siblings of survey respondents were invited to complete a similar survey. Descriptive statistics for demographics, disease severity, center, and method of survey completion were computed for participants and controls. Comparisons were made between participants and non-participants to assess for response bias and between CHD participants and sibling controls to assess for baseline differences. Among the 14,322 eligible participants, there were 3133 respondents (21.9%) from 48 U.S. states with surveys returned for inclusion in the study. Sibling contact information was provided by 691 respondents, with surveys returned by 326 siblings (47.2%). The median age of participants was 32.8 years at time of survey completion, with an interquartile range of 27.2 years to 39.7 years and an overall range of 20.1 to 82.9 years. Participants were predominantly female (55.1%) and of non-Hispanic White race/ethnicity (87.1%). There were no differences between participants and non-participants regarding severity of CHD. Compared to non-participants, participants were more likely to be female, of older age, and be of non-Hispanic White race/ethnicity. Enrolled siblings were more likely to be female and slightly younger than participants. With surveys from 3133 participants from across the U.S., CHD PULSE is poised to provide keen insights into the lifelong journey of those living with CHD, extending beyond mere survival. These insights will offer opportunities for informing strategies to enhance and improve future outcomes for this population of patients.

Sections du résumé

BACKGROUND BACKGROUND
With improved survival of adults with congenital heart disease (CHD) comes a need to understand the lifelong outcomes of this population. The aim of this paper is to describe the rationale and design of Congenital Heart Disease Project to Understand Lifelong Survivor Experience (CHD PULSE), a study to determine long-term medical, neurocognitive, and psychosocial outcomes among adults with a history of intervention for CHD and to identify factors associated with those outcomes.
METHODS METHODS
CHD PULSE is a cross-sectional survey conducted from September 2021 to April 2023 among adults aged 18 and older with a history of at least one intervention for CHD at one of 11 participating U.S. centers in the Pediatric Cardiac Care Consortium. Participants with CHD were asked to complete a 99-question survey on a variety of topics including: demographics, surgeries, health insurance, health care, heart doctors, general health, height and weight, education and work history, reproductive health (for women only), and COVID-19. To construct a control group for the study, siblings of survey respondents were invited to complete a similar survey. Descriptive statistics for demographics, disease severity, center, and method of survey completion were computed for participants and controls. Comparisons were made between participants and non-participants to assess for response bias and between CHD participants and sibling controls to assess for baseline differences.
RESULTS RESULTS
Among the 14,322 eligible participants, there were 3133 respondents (21.9%) from 48 U.S. states with surveys returned for inclusion in the study. Sibling contact information was provided by 691 respondents, with surveys returned by 326 siblings (47.2%). The median age of participants was 32.8 years at time of survey completion, with an interquartile range of 27.2 years to 39.7 years and an overall range of 20.1 to 82.9 years. Participants were predominantly female (55.1%) and of non-Hispanic White race/ethnicity (87.1%). There were no differences between participants and non-participants regarding severity of CHD. Compared to non-participants, participants were more likely to be female, of older age, and be of non-Hispanic White race/ethnicity. Enrolled siblings were more likely to be female and slightly younger than participants.
CONCLUSIONS CONCLUSIONS
With surveys from 3133 participants from across the U.S., CHD PULSE is poised to provide keen insights into the lifelong journey of those living with CHD, extending beyond mere survival. These insights will offer opportunities for informing strategies to enhance and improve future outcomes for this population of patients.

Identifiants

pubmed: 39299630
pii: S0002-8703(24)00236-9
doi: 10.1016/j.ahj.2024.09.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Matthew E Oster (ME)

Department of Pediatrics, Emory University School of Medicine. Electronic address: osterm@kidsheart.com.

Yanxu Yang (Y)

Department of Pediatrics, Emory University School of Medicine.

Caroline Shi (C)

Department of Pediatrics, Emory University School of Medicine.

Susan Anderson (S)

Department of Pediatrics, Emory University School of Medicine.

Jessica Knight (J)

Department of Epidemiology and Biostatistics, University of Georgia College of Public Health.

Logan G Spector (LG)

Department of Pediatrics, University of Minnesota Masonic Children's Hospital.

Osamah Aldoss (O)

Division of Pediatric Cardiology Stead Family Department of Pediatrics, University of Iowa and Carver College of Medicine, University of Iowa Children's Hospital, Iowa City, IA.

Charles E Canter (CE)

Division of Pediatric Cardiology, Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri, USA.

Mansi Gaitonde (M)

Department of Pediatrics, University of Texas Southwestern Medical Center, Children's Medical Center, Dallas, TX.

Gugurmurthy Hiremath (G)

Department of Pediatrics, University of Minnesota Masonic Children's Hospital.

Anitha John (A)

Children's National Medical Center.

Deborah J Kozik (DJ)

Department of Cardiovascular and Thoracic Surgery, University of Louisville School of Medicine, Norton Children's Hospital.

Bradley S Marino (BS)

Department of Heart, Vascular, & Thoracic, Division of Cardiology and Cardiovascular Medicine, Cleveland Clinic Children's, Cleveland, OH.

Kimberly E McHugh (KE)

Medical University of South Carolina.

David Overman (D)

Division of Cardiovascular Surgery, Children's Minnesota, Mayo Clinic-Children's Minnesota Cardiovascular Collaborative, Minneapolis, MN.

Geetha Raghuveer (G)

Childrens Mercy Hospital.

James Louis (J)

Augusta University, Augusta, GA.

Jeffrey Jacobs (J)

Department of Surgery, University of Florida, Gainesville.

Michelle Gurvitz (M)

Department Of Cardiology, Harvard University, Boston Children's Hospital.

Grace Smith (G)

Department of Pediatrics, Emory University School of Medicine.

J'Neka S Claxton (JS)

Department of Pediatrics, Emory University School of Medicine.

Kristina Kuo (K)

Department of Pediatrics, Emory University School of Medicine.

Jessica M Flores (JM)

Department of Pediatrics, Emory University School of Medicine.

Romie N Velani (RN)

Department of Pediatrics, Emory University School of Medicine.

Amanda Thomas (A)

Department of Pediatrics, Emory University School of Medicine.

Ann Mertens (A)

Department of Pediatrics, Emory University School of Medicine.

Mason Basler (M)

Division of Pediatric Cardiology, Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri, USA.

Violet Carey (V)

Department of Pediatrics, University of Louisville School of Medicine, Norton Children's Hospital.

Charlotte Gavalas (C)

Augusta University, Augusta, GA.

Madison Johnson (M)

Medical University of South Carolina.

Anita Mathews (A)

Children's National Medical Center.

Jennifer Nelson (J)

Childrens Mercy Hospital.

Katrin O'Grady (K)

Children's Minnesota.

Emily Riley (E)

Division of Pediatric Cardiology Stead Family Department of Pediatrics, University of Iowa and Carver College of Medicine, University of Iowa Children's Hospital, Iowa City, IA.

Michelle Roesler (M)

Department of Pediatrics, University of Minnesota Masonic Children's Hospital.

Amber Sykes (A)

Department of Heart, Vascular, & Thoracic, Division of Cardiology and Cardiovascular Medicine, Cleveland Clinic Children's, Cleveland, OH.

Daniel Young (D)

Department of Pediatrics, University of Texas Southwestern Medical Center, Children's Medical Center, Dallas, TX.

Lazaros K Kochilas (LK)

Department of Pediatrics, Emory University School of Medicine.

Classifications MeSH